Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis

Yide Mei1, Chongwei Xie, Wei Xie

  • 1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.

Neoplasia (New York, N.Y.)
|November 1, 2007
PubMed

Insights

Camptothecin (CPT) induces apoptosis by upregulating the BH3-only protein Noxa, independent of p53. The balance between Noxa and antiapoptotic Mcl-1 determines cancer cell susceptibility to CPT.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Pathways

Background:

  • Camptothecin (CPT) is known to induce apoptosis in cancer cells, but the underlying molecular mechanisms require further elucidation.
  • The role of BH3-only proteins in CPT-induced apoptosis is not fully understood.
  • Regulation of apoptosis by signaling pathways like PI3K/Akt is crucial in cancer therapy.

Purpose of the Study:

  • To investigate the molecular mediators of CPT-induced apoptosis.
  • To identify the signaling pathways regulating these mediators.
  • To determine the role of Noxa and Mcl-1 in CPT-induced apoptosis and their interplay.

Main Methods:

  • Upregulation of Noxa and Mcl-1 was assessed during CPT treatment.
  • Phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway involvement was investigated.
  • Luciferase assays and cAMP response element binding protein (CREB) knockdown were used to study transcriptional regulation.
  • Small interfering ribonucleic acid (siRNA) and short hairpin ribonucleic acid (shRNA) were employed to knock down Noxa and Mcl-1, respectively.
  • Immunoprecipitation assays were performed to analyze protein interactions.
  • Cell viability assays were conducted to assess apoptosis levels.

Main Results:

  • BH3-only protein Noxa is upregulated during CPT-induced apoptosis, independent of p53.
  • The PI3K/Akt signaling pathway mediates Noxa induction via CREB transcriptional activity.
  • Blocking Noxa expression significantly reduces CPT-induced apoptosis, confirming Noxa as an essential mediator.
  • Antiapoptotic Mcl-1 is also upregulated via the PI3K/Akt pathway.
  • Noxa interacts with Mcl-1, and Mcl-1 knockdown potentiates CPT-induced apoptosis, while Mcl-1 overexpression confers resistance.
  • The ratio of Noxa to Mcl-1 expression correlates with HeLa cell susceptibility to CPT.

Conclusions:

  • Noxa is a critical mediator of CPT-induced apoptosis, regulated by the PI3K/Akt/CREB pathway.
  • The antiapoptotic protein Mcl-1 counteracts CPT-induced apoptosis by interacting with Noxa.
  • The balance between Noxa and Mcl-1 expression levels dictates cancer cell fate upon CPT treatment, highlighting a potential therapeutic target.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...